OECD Science, Technology and Industry Scoreboard 2011

image of OECD Science, Technology and Industry Scoreboard 2011

This tenth edition of the OECD Science, Technology and Industry (STI) Scoreboard builds on the OECD’s 50 years of indicator development to present major world trends in knowledge and innovation. It analyses a wide set of indicators of science, technology, globalisation and industrial performance in OECD and major non-OECD countries (notably Brazil, the Russian Federation, India, Indonesia, China and South Africa) and includes some experimental indicators that provide insight into new areas of policy interest.

English Also available in: French

Health innovation

OECD countries are faced with the health-care challenges of ageing populations and others, such as increasingly drug-resistant diseases and the risk of global pandemics. Innovation is a critical means of improving the capacity of health systems to address these problems while containing escalating costs. The public sector plays a significant role alongside business and non-profit organisations, by supporting R&D directly but also through the procurement of new treatments resulting from R&D. Government budget appropriations or outlays for R&D (GBAORD) indicate that direct government support of health-related R&D in OECD countries was about 0.1% of their combined GDP in 2008. The United States is by far the largest funder in both absolute and relative terms, at just over 0.3% of GDP spent on health R&D.

English Also available in: French

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error